4D Molecular Therapeutics (FDMT) Prepaid Assets (2019 - 2026)

4D Molecular Therapeutics (FDMT) has reported Prepaid Assets for 8 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 30.04% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (up 30.04% YoY), while the FY2025 annual figure was $10.5 million, up 4.22% from the prior year.
• Prepaid Assets climbed to $14.5 million in Q1 2026 per FDMT's latest filing, from $10.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $14.5 million in Q1 2026 and bottomed at $4.8 million in Q3 2022.
• Historically, Prepaid Assets has averaged $8.7 million across 5 years, with a median of $8.6 million in 2023.
• On a YoY basis, Prepaid Assets climbed as much as 87.8% in 2022 and fell as far as 17.73% in 2022.
• 4D Molecular Therapeutics' Prepaid Assets stood at $7.0 million in 2022, then grew by 20.11% to $8.4 million in 2023, then advanced by 20.33% to $10.1 million in 2024, then advanced by 4.22% to $10.5 million in 2025, then surged by 38.1% to $14.5 million in 2026.
• Business Quant data shows FDMT's Prepaid Assets at $14.5 million in Q1 2026, $10.5 million in Q4 2025, and $7.3 million in Q3 2025.